12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga · 4d ago
Gainers
- Catheter Precision (AMEX:VTAK) shares moved upwards by 216.8% to $0.72 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.9 million.
- Helius Medical Tech (NASDAQ:HSDT) shares rose 104.73% to $1.73.
- Vaxart (NASDAQ:VXRT) shares rose 78.26% to $0.7. The market value of their outstanding shares is at $159.8 million.
- Kazia Therapeutics (NASDAQ:KZIA) stock moved upwards by 36.43% to $7.17. The market value of their outstanding shares is at $40.0 million.
- NuCana (NASDAQ:NCNA) shares moved upwards by 30.87% to $0.19. The market value of their outstanding shares is at $1.1 million.
- SunLink Health Systems (AMEX:SSY) shares moved upwards by 17.17% to $1.16. The market value of their outstanding shares is at $8.1 million.
Losers
- CARISMA Therapeutics (NASDAQ:CARM) stock fell 33.3% to $0.74 during Wednesday's pre-market session. The company's market cap stands at $30.9 million.
- Gelteq (NASDAQ:GELS) stock declined by 17.29% to $2.44. The company's market cap stands at $23.0 million.
- Windtree Therapeutics (NASDAQ:WINT) shares declined by 13.07% to $0.7. The market value of their outstanding shares is at $2.5 million.
- Klotho Neurosciences (NASDAQ:KLTO) stock decreased by 12.94% to $1.75. The company's market cap stands at $56.8 million.
- Tempest Therapeutics (NASDAQ:TPST) shares fell 12.84% to $7.74. The market value of their outstanding shares is at $28.5 million.
- Cabaletta Bio (NASDAQ:CABA) shares declined by 10.64% to $2.1. The company's market cap stands at $106.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.